Cephalon

2 Decision Makers · 2 Verified Contacts

📍 Malvern, Pennsylvania, United StatesBiotechnology🗓 Est. 1987👥 1001–5000 employees

About Cephalon

Cephalon is a global biopharmaceutical company dedicated to discovering, developing and bringing to market medications to improve the

Leadership & Decision Makers

Contact details of 2 Cephalon decision makers

Frank Baldino, Jr.

Chairman & CEO

Piyush Patel

Director

General Emails

General company emails, e.g. customer support lines

    orporatecommunications@cephalon.com

    Unclassified inbox

    businessdevelopment@cephalon.com

    Unclassified inbox

    rprettym@cephalon.com

    Unclassified inbox

    pcastagn@cephalon.com

    Unclassified inbox

    pmudipal@cephalon.com

    Unclassified inbox

    d@cephalon.com

    Unclassified inbox

Similar Companies like Cephalon

Seagen

seagen.com
Biotechnology · Bothell, Washington, United States · Est. 1998 · 1001–5000 employees · $500M–$1B

HQ: Bothell, Washington, United States

Biotechnology · Cheshire, Connecticut, United States · Est. 1992 · 1001–5000 employees

HQ: Cheshire, Connecticut, United States

Fulgent Therapeutics

fulgentgenetics.com
Biotechnology · Temple City, California, United States · Est. 2011 · 1001–5000 employees

HQ: Temple City, California, United States

Horizon Pharma

horizontherapeutics.com
Pharmaceuticals · Northbrook, Illinois, United States · Est. 2005 · 1001–5000 employees

HQ: Northbrook, Illinois, United States

Kite Pharma

kitepharma.com
Biotechnology · Los Angeles, CA · Est. 2009 · 101–250 employees

HQ: Los Angeles, CA

Explore similar firms in the Biotechnology sector

Company Info

Last updated: 29/07/2025

610-344-0200

Malvern, Pennsylvania, United States

Specialization: Therapeutics,
Legal Name: Cephalon Inc.
Business Type: Delisted
Employees: 1001-5000
Founded Date: 1987
Number of Exits: 1
Company Type: For Profit
Stock Symbol: NASDAQ:CEPH
Operating Status: Closed
Investor Type: Venture Capital
Phone Number: 610-344-0200
Last Investment Activity: Oct 19, 2023
Investments Activity: Oct 19, 2023 Nov 26, 2020 Nov 26, 2020

Our service is undergoing beta testing, and you can get all the information that is closed on this page for free by registering. You will not need to provide your credit/debit card details.